top of page

January 2026: Healthcare M&A Snapshot

  • Eclipse Corporate Finance
  • 8 hours ago
  • 2 min read
A summary of the key M&A, private equity and venture capital deals across the UK healthcare sector in January 2026.

View our summary of the key M&A, private equity and venture capital deals across the UK healthcare sector in January 2026 below.



Notable Sector Deals: January 2026


LDC’s investment into myHappymind


  • myHappymind, a leading digital mental health and wellbeing programme for schools, has secured a minority investment from LDC

  • Founded in 2017, the business delivers interactive mental health content to over 1,900 schools across the UK

  • The business has grown rapidly in recent years, driven by increasing demand for preventative mental health support in schools

  • LDC’s investment will support expansion into more schools in the UK and internationally, alongside ongoing product development

  • The deal highlights strong M&A and investment activity in preventative mental health services


Acquisition of Care Quality Pharmacy by Pharmacy2U


  • Pharmacy2U has acquired Care Quality Pharmacy, a specialist pharmacy provider focused on supporting care homes and residential care settings

  • Pharmacy2U is the UK’s largest online pharmacy, serving millions of NHS patients through digital prescription management, dispensing and delivery

  • The acquisition represents a strategic move by Pharmacy2U into the care home pharmacy segment, broadening its exposure beyond consumer-facing distance-selling services

  • The deal reflects ongoing consolidation within pharmacy services as scaled operators seek to diversify revenue streams and deploy technology effectively


Rockpool’s investment into Carescribe


  • Rockpool has invested in CareScribe, a rapidly growing assistive technology company focused on improving accessibility, productivity and inclusivity for disabled and neurodivergent people in education and the workplace.

  • CareScribe offers software tools including Caption.Ed, TalkType and Medincle to support independent working and studying

  • The investment will support CareScribe’s next phase of growth: scaling product‑led user adoption, expanding its software portfolio, and accelerating growth across workplace and education markets

  • The deal underscores strong investor appetite for scalable technology platforms addressing the needs of disabled and neurodivergent individuals


Mayden’s acquisition of ClinicLetter.ai


  • ClinicLetter.ai (CLAI), an ambient scribe solution built for the NHS, has joined G Square-backed Mayden to expand digital support for clinicians.

  • CLAI uses Ambient Voice Technology to reduce manual data entry and has demonstrated up to a 30% reduction in administrative workload

  • The addition strengthens Mayden’s mission to transform health and care by expanding its digital offering across the NHS, local authorities, VCSEs and the private sector

  • CLAI will sit alongside Mayden’s existing products (iaptus, theseus and bacpac), broadening support for clinical services



Healthcare Market Activity: January 2026


Private Equity Activity


Sub-sector

Target

Acquirer / Investor

Exiting PE

Digital Health

Carescribe

Rockpool

N/A

Digital Health

Mayden

(G Square)

N/A

Digital Health

PPD

Agilio

(Five Arrows)

N/A

Elderly Care

3 x homes in Scotland

Care Concern (Downing)

N/A

Medical Equipment

Derbyshire Mobility

Eden Mobility (Foresight)

N/A

Medical Equipment

Iskus Health UK

Fannin UK

(Invest Industrial)

N/A

Medical Equipment

Medguard Equipment

Mediq

(Advent)

N/A

Mental Health

MyHappyMind

LDC

N/A

Pharmacy

Care Quality Pharmacy

Pharmacy2U

(G Square)

N/A

Pharma Services

Bridge Medical Consulting

Red Nucleus

(THL)

N/A

Pharma Services

Uptake

Prescient

(Bridgepoint)

N/A

Specialist Care

Awelon Healthcare

Iris Care

(Ancala)

N/A

Training

Caring For Care

Impact Futures

(August)

N/A


Venture Capital Activity


Target

Description

Lead Investor

Investment

Emerald

Proactive healthcare platform that unifies health data, AI insights, and GP-led care

Boost Capital Partners

$2m

Eolas Medical

Provides AI-powered clinical knowledge tools

Acton Capital

$12m

Evaro

Embeddable digital pharmacy infrastructure and prescribing tools

Albion VC

$25m

Nuclera

Antibody engineering

Elevage Medical Technologies

$12m


 
 
 

Eclipse Corporate Finance Limited is a limited company registered in England & Wales (registered number 11791669)

The company is regulated by the Institute of Chartered Accountants of Scotland for a range of investment business activities 

  • LinkedIn
bottom of page